CervoMed

Forecast & Rating6 analysts currently cover CervoMed, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $15.00, about 569.6% upside from the current price of $2.24. Price targets range from $7.00 to $25.00 — a wide spread, showing clear disagreement over just how much CervoMed can rise. Historically, about 34.7% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study CervoMed closely still see room for the stock to rise. Data as of Oct 19, 2026; for reference only and not investment advice.